The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck
- PMID: 20086182
- PMCID: PMC2818282
- DOI: 10.1158/1940-6207.CAPR-08-0228
The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck
Abstract
Caspase 8 (CASP8) is an apoptosis-related cysteine peptidase involved in the death receptor pathway and likely in the mitochondrial pathway. A CASP8 promoter region six-nucleotide deletion/insertion (-652 6N ins/del) variant and a coding region D302H polymorphism are reportedly important in cancer development, but no reported study has assessed the associations of these genetic variations with risk of head and neck cancer. In a hospital-based study of non-Hispanic whites, we genotyped CASP8 -652 6N del and 302H variants in 1,023 patients with squamous cell carcinoma of the head and neck (SCCHN) and 1,052 cancer-free controls. Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression models. The CASP8 -652 6N del variant genotypes or haplotypes were inversely associated with SCCHN risk (adjusted OR, 0.70; 95% CI, 0.57-0.85 for the ins/del + del/del genotypes compared with the ins/ins genotype; adjusted OR, 0.73; 95% CI, 0.55-0.97 for the del-D haplotype compared with the ins-D haplotype). Furthermore, the number of the CASP8 -652 6N del (but not 302H) variant allele tended to correlate with increased levels of camptothecin-induced p53-mediated apoptosis in T lymphocytes from 170 cancer-free controls. We concluded that the CASP8 -652 6N del variant allele may contribute to the risk of developing SCCHN in non-Hispanic white populations. Further validation by population-based case-control studies and rigorous mechanistic studies is warranted.
Figures

Similar articles
-
The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.J Urol. 2013 Aug;190(2):717-22. doi: 10.1016/j.juro.2013.01.008. Epub 2013 Jan 9. J Urol. 2013. PMID: 23313206
-
Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.Hum Mutat. 2008 Dec;29(12):1443-51. doi: 10.1002/humu.20803. Hum Mutat. 2008. PMID: 18563783 Free PMC article.
-
Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.Mol Carcinog. 2010 Sep;49(9):810-7. doi: 10.1002/mc.20656. Mol Carcinog. 2010. PMID: 20572163
-
Functional variants in cell death pathway genes and risk of pancreatic cancer.Clin Cancer Res. 2008 May 15;14(10):3230-6. doi: 10.1158/1078-0432.CCR-08-0177. Clin Cancer Res. 2008. PMID: 18483392
-
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer.Clin Cancer Res. 2009 Apr 1;15(7):2567-72. doi: 10.1158/1078-0432.CCR-08-2829. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276244
Cited by
-
Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.J Biomed Sci. 2023 Aug 9;30(1):65. doi: 10.1186/s12929-023-00953-z. J Biomed Sci. 2023. PMID: 37559138 Free PMC article. Review.
-
Identification of a secondary promoter of CASP8 and its related transcription factor PURα.Int J Oncol. 2014 Jul;45(1):57-66. doi: 10.3892/ijo.2014.2436. Epub 2014 May 9. Int J Oncol. 2014. PMID: 24819879 Free PMC article.
-
A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.FASEB J. 2013 Apr;27(4):1404-12. doi: 10.1096/fj.12-223420. Epub 2012 Dec 27. FASEB J. 2013. PMID: 23271051 Free PMC article.
-
Fine-mapping CASP8 risk variants in breast cancer.Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):176-81. doi: 10.1158/1055-9965.EPI-11-0845. Epub 2011 Nov 4. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22056502 Free PMC article.
-
CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.Carcinogenesis. 2010 May;31(5):850-7. doi: 10.1093/carcin/bgq047. Epub 2010 Feb 22. Carcinogenesis. 2010. PMID: 20176653 Free PMC article.
References
-
- Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res. 2007;86:104–114. - PubMed
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res. 1990;50:6502–6507. - PubMed
-
- Ho T, Wei Q, Sturgis EM. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck. 2007;29:682–699. - PubMed
-
- Gattas GJ, de Carvalho MB, Siraque MS, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28:819–826. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous